We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mild-to-Moderate Hypertriglyceridemia Leads to Acute Pancreatitis

By LabMedica International staff writers
Posted on 23 Nov 2016
Print article
Image: A histopathology of acute pancreatitis showing hemorrhage, parenchymal necrosis, and fat necrosis (Photo courtesy of Kathryn Lindsey, MD).
Image: A histopathology of acute pancreatitis showing hemorrhage, parenchymal necrosis, and fat necrosis (Photo courtesy of Kathryn Lindsey, MD).
Pancreatitis is very painful and it may lead to fatalities and until now, medical science has connected the risk of developing this illness to gallstone, a high intake of alcohol and very high concentrations of blood fats or triglycerides.

Normal levels of blood triglycerides would typically be 0-2 mmol/L, while 2-10 is classified as a mild to moderate increase. If blood fat levels rise above 10 mmol/L it is considered a very high increase and previously, this was considered the risk factor to look for in relation to pancreatitis.

Clinical biochemists and their colleagues at the Copenhagen University Hospital (Herlev, Denmark) carried out a prospective cohort study examines individuals from the Copenhagen General Population Study in 2003 to 2015 and the Copenhagen City Heart Study initiated in 1976 to 1978 with follow-up examinations in 1981 to1983, 1991 to 1994, and in 2001 to 2003. Median follow-up was 6.7 years and includes 116, 550 individuals with a triglyceride measurement from the Copenhagen General Population Study and the Copenhagen City Heart Study. All individuals were followed until the occurrence of an event, death, emigration, or end of follow-up, in November 2014.

The scientists showed that even a 2 mmol/L significantly increases the risk of pancreas inflammation, and the risk is nine times higher with blood triglycerides levels at 5-10 mmol/L. Compared with individuals with plasma triglyceride levels less than 89 mg/dL (<1 mmol/L), the multivariable adjusted hazard ratios (HRs) for acute pancreatitis were 1.6; for individuals with triglyceride levels of 89 mg/dL to 176 mg/dL, HR was 2.3. The HRs increased as triglycerides incrementally until for individuals with triglyceride levels greater than or equal to 443 mg/dL (≥5.00 mmol/L), the HR reached 8.7. Corresponding HRs for myocardial infarction were followed a similar correlation.

Børge Nordestgaard, MD, DMSc, a professor and the lead investigator said, “Until now, medical science has focused primarily on high blood cholesterol, but our study shows that we should also pay attention to more common fats. Mild to moderate levels of blood fats cause a lot more diseases than we have hitherto been aware of and we need many more studies in this area. I know that currently studies are undertaken that investigate whether lowering the levels of blood fats also lowers the risk of developing cardiovascular diseases.” The study was published on November 7, 2016, in the Journal of the American Medical Association Internal Medicine.

Related Links:
Copenhagen University Hospital

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel

Breakthrough Diagnostic Approach to Significantly Improve TB Detection

Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying TB, preventing its spread, and ultimately working towards its eradication. TB can remain dormant in the body for... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.